Win Trust Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.50 M
as on 03-07-2024
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.89 M
as on 03-07-2024
- Revenue 6.77%
(FY 2022)
- Profit -95.59%
(FY 2022)
- Ebitda -5.32%
(FY 2022)
- Net Worth 0.91%
(FY 2022)
- Total Assets -13.58%
(FY 2022)
About Win Trust Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.89 M.
Kamal Khurana, Arvindpal Khurana, Jaspavit Khurana, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239PB1995PLC016979
- Company No.
016979
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Aug 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Punjab, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Win Trust Pharmaceuticals Limited offer?
Win Trust Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Capsules, Tea & Coffee, Fruit Tea, Ayurvedic & Herbal Health Supplement, Herbal Juice, Digestive System Drugs & Medicines, Digestive Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Win Trust Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arvindpal Khurana | Managing Director | 30-Aug-1995 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kamal Khurana | Director | 01-Apr-2007 | Current |
Jaspavit Khurana | Director | 01-Sep-2018 | Current |
Anmol Khurana | Director | 26-Feb-2022 | Current |
Financial Performance of Win Trust Pharmaceuticals.
Win Trust Pharmaceuticals Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.77% increase. The company also saw a substantial fall in profitability, with a 95.59% decrease in profit. The company's net worth moved up by a moderate rise of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Win Trust Pharmaceuticals?
In 2022, Win Trust Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dr Kooin Enterprises Private LimitedActive 8 years 7 months
Arvindpal Khurana, Jaspavit Khurana and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 31 Jan 2023 | ₹2.89 M | Open |
Hdfc Bank Limited Creation Date: 24 Oct 2020 | ₹2.00 M | Open |
How Many Employees Work at Win Trust Pharmaceuticals?
Win Trust Pharmaceuticals has a workforce of 6 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Win Trust Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Win Trust Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.